Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
small molecule |
| gptkbp:approvalYear |
2020
|
| gptkbp:approvedBy |
gptkb:China
|
| gptkbp:ATCCode |
L01EX23
|
| gptkbp:CASNumber |
1360907-17-0
|
| gptkbp:chemicalFormula |
C22H16F2N4O2S
|
| gptkbp:developedBy |
Hutchmed
|
| https://www.w3.org/2000/01/rdf-schema#label |
surufatinib
|
| gptkbp:mechanismOfAction |
gptkb:receptor_tyrosine_kinase
|
| gptkbp:molecularWeight |
438.45 g/mol
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
HMPL-012
Sulfatinib |
| gptkbp:target |
gptkb:FGFR1
gptkb:VEGFR1 gptkb:VEGFR2 gptkb:VEGFR3 CSF-1R |
| gptkbp:usedFor |
gptkb:pancreatic_neuroendocrine_tumors
neuroendocrine tumors non-pancreatic neuroendocrine tumors |
| gptkbp:bfsParent |
gptkb:Hutchison_MediPharma
|
| gptkbp:bfsLayer |
7
|